Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Clinical trial NCT06665646 · RECRUITING
Trial details
- NCT number
- NCT06665646
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-14
- Primary completion
- 2026-07-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.